Models of cardiac fibrosis

Drug Discovery Today: Disease Models

Volumn 3, Issue 3, 2006, Pages 291-295

  Rajamannan, Nalini M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; EARLY GROWTH RESPONSE FACTOR 1; MYC PROTEIN; MYOCYTE ENHANCER FACTOR 2; MYOSIN; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN BETA; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN 2; NATRIURETIC FACTOR; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR GATA 4; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG;

ANIMAL MODEL; CARDIOMYOPATHY; CELL INTERACTION; CELL ISOLATION; COMPUTER MODEL; DISEASE MODEL; EXPERIMENTAL ANIMAL; FIBROBLAST CULTURE; HEART MUSCLE FIBROSIS; HYPERTROPHIC CARDIOMYOPATHY; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; MUTATIONAL ANALYSIS; NONHUMAN; PARACRINE SIGNALING; PATHOGENESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION;

EID: 33751226276     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2006.10.012     Document Type: Review

References (37)

1. Marx J. Heart disease. How to subdue a swelling heart. Science 300 (2003) 1492-1496
2. Maron B.J., et al. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N. Engl. J. Med. 316 (1987) 780-789
3. Jain M., et al. Mesenchymal stem cells in the infarcted heart. Coron. Artery Dis. 16 (2005) 93-97
4. Mitsumoto M., et al. Nitric oxide-mediated upregulation of the TGF-beta-inducible early response gene-1 (TIEG1) in human fibroblasts by mRNA stabilization independent of TGF-beta. Free Radic. Biol. Med. 34 (2003) 1607-1613
5. Iwasaki T., et al. Marked attenuation of production of collagen type I from cardiac fibroblasts by dehydroepiandrosterone. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E1222-E1228
6. Fredj S., et al. Interactions between cardiac cells enhance cardiomyocyte hypertrophy and increase fibroblast proliferation. J. Cell Physiol. 202 (2005) 891-899
7. Yano T., et al. Intracardiac fibroblasts, but not bone marrow derived cells, are the origin of myofibroblasts in myocardial infarct repair. Cardiovasc. Pathol. 14 (2005) 241-246
8. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol. Rev. 79 (1999) 215-262
9. Weber K.T. Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation 96 (1997) 4065-4082
10. Brilla C.G., et al. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism. J. Hypertens. Suppl. 15 (1997) S13-S19
11. McEwan P.E., et al. Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo. Circulation 98 (1998) 2765-2773
12. Ramires F.J., et al. Myocardial fibrosis associated with aldosterone or angiotensin II administration: attenuation by calcium channel blockade. J. Mol. Cell Cardiol. 30 (1998) 475-483
13. Icardo J.M., and Ojeda J.L. Effects of colchicine on the formation and looping of the tubular heart of the embryonic chick. Acta Anat. (Basel) 119 (1984) 1-9
14. Harvey R.P. Patterning the vertebrate heart. Nat. Rev. Genet. 3 (2002) 544-556
15. Olson E.N., and Schneider M.D. Sizing up the heart: development redux in disease. Genes Dev. 17 (2003) 1937-1956
16. Solloway M.J., and Harvey R.P. Molecular pathways in myocardial development: a stem cell perspective. Cardiovasc. Res. 58 (2003) 264-277
17. Soonpaa M.H., et al. Cardiomyocyte DNA synthesis and binucleation during murine development. Am. J. Physiol. 271 5 Pt 2 (1996) H2183-H2189
18. Arad M., Seidman J.G., and Seidman C.E. Phenotypic diversity in hypertrophic cardiomyopathy. Human Molecular Genetics 11 (2002) 2499-2506
19. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. Jama 287 (2002) 1308-1320
20. Seidman J.G., and Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104 (2001) 557-567
21. Vikstrom K.L., et al. A murine model for hypertrophic cardiomyopathy. Z Kardiol 84 Suppl 4 (1995) 49-54
22. Marian A.J., et al. A transgenic rabbit model for human hypertrophic cardiomyopathy. J. Clin. Invest. 104 (1999) 1683-1692
23. Oberst L., et al. Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice. J. Clin. Invest. 102 (1998) 1498-1505
24. Tardiff J.C., et al. A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J. Clin. Invest. 101 (1998) 2800-2811
25. Yang Q., et al. A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy. J. Clin. Invest. 102 (1998) 1292-1300
26. James J., et al. Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy. Circ. Res. 87 (2000) 805-811
27. Geisterfer-Lowrance A.A., et al. A mouse model of familial hypertrophic cardiomyopathy. Science 272 (1996) 731-734
28. Wolf C.M., et al. Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia. Proc. Natl. Acad. Sci. U S A 102 (2005) 18123-18128
29. McMullen J.R., and Izumo S. Mechanisms controlling heart growth in mammals. In: Hall M.N., et al. (Ed). Cell Growth: Control of Cell Size (2004), Cold Springs Harbor 549-603
30. Akazawa H., and Komuro I. Roles of cardiac transcription factors in cardiac hypertrophy. Circ. Res. 92 (2003) 1079-1088
31. Kook H., et al. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J. Clin. Invest. 112 (2003) 863-871
32. Hunter J.J., and Chien K.R. Signaling pathways for cardiac hypertrophy and failure. N. Engl. J. Med. 341 (1999) 1276-1283
33. Miyata S., et al. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ. Res. 86 (2000) 386-390
34. Molkentin J.D., and Dorn II I.G. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu. Rev. Physiol. 63 (2001) 391-426
35. Grimm D., et al. Regulation of extracellular matrix proteins in pressure-overload cardiac hypertrophy: effects of angiotensin converting enzyme inhibition. J. Hypertens. 16 (1998) 1345-1355
36. Gao X.M., et al. Regression of pressure overload-induced left ventricular hypertrophy in mice. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H2702-H2707
37. Rajamannan N.M., et al. TGFbeta inducible early gene-1 (TIEG1) and cardiac hypertrophy: Discovery and characterization of a novel signaling pathway. J. Cell Biochem. (2006) Aug 3 [Epub ahead of print]